Anuh Pharma Ltd. (ANUHPHR): Anuh Pharma Share Price rises 11.12% as stock gains to Rs 90.27

Anuh Pharma Share Price was at Rs 90.27, up 11.12% from the previous close of Rs 81.24, with market capitalisation at Rs 814.22 Cr as of 07 September 2026 at 12:22:58 PM IST. The move puts Anuh Pharma Ltd. in focus in today’s share market today and adds it to stocks in news, even though the latest Univest data confirms the price event without establishing a company-specific catalyst. That makes the Anuh Pharma Share Price story relevant for investors who track price action alongside valuation and sector context. In this Anuh Pharma Stock News update, the key question is whether the share price rise aligns with the company’s fundamentals and its place in the pharmaceuticals & drugs universe.

For readers following Anuh Pharma Share Price Today, the stock opened at Rs 80.84 and moved straight to the day’s high of Rs 90.27, which also matched the last traded level in the session. That pattern shows a clean share price gain from the opening print, and it is enough to explain why the stock is appearing among top gainers today and other stocks rising today on market screens. Univest tracks the same move in Anuh Pharma Share Price Live and Anuh Pharma Share Price Update format so investors can connect the day’s price rise with the broader stock performance narrative.

Anuh Pharma Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 90.27
Previous Close	Rs 81.24
Today's Move	Rs 9.03 (+11.12%)
Open	Rs 80.84
High	Rs 90.27
Low	Rs 80.84
Turnover	Rs 0.78 crore
Market Capitalisation	Rs 814.22 crore
Market Cap Category	Micro Cap

Anuh Pharma Ltd. (ANUHPHR) rose to Rs 90.27 from the previous close of Rs 81.24, a move of Rs 9.03 or 11.12%. The stock opened at Rs 80.84, reached a high of Rs 90.27, recorded a low of Rs 80.84.

Anuh Pharma Share Price Today reflects a strong intraday rise of Rs 9.03, or 11.12%, from the previous close of Rs 81.24 to Rs 90.27. The stock traded between Rs 80.84 and Rs 90.27 during the ongoing session, which means the current print is at the day’s high. Turnover stood at Rs 0.78 Cr, keeping the focus on price action rather than any implied trade intensity. For readers scanning Anuh Pharma NSE and Anuh Pharma BSE updates, the key takeaway is simple: the stock is trading firmly above the prior session reference and is holding the full day’s range at the time of writing.

Anuh Pharma Ltd. (ANUHPHR) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 814.22 crore
P/E Ratio	18.43x
P/B Ratio	2.24x
ROE	12.1%
ROCE	16.02%
EPS	Rs 4.41
Book Value Per Share	Rs 36.28
Dividend Yield	1.85%

Anuh Pharma Ltd. (ANUHPHR) fundamental metrics show P/E 18.43x, P/B 2.24x, ROE 12.1%, ROCE 16.02%. These figures provide context only and are not a buy or sell signal.

Anuh Pharma Ltd. has a market capitalisation of Rs 814.22 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 18.43x, P/B at 2.24x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.1% and ROCE of 16.02%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 4.41, book value per share of Rs 36.28, dividend yield of 1.85%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.83x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	18.43x
Benchmark Median P/E	32.83x
Benchmark Average P/E	48.79x
Benchmark P/E Range	3.2x to 659.73x
Company P/B Ratio	2.24x
Benchmark Median P/B	2.92x
Company ROE	12.1%
Benchmark Median ROE	11.78%
Company ROCE	16.02%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 814.22 crore
Benchmark Median Market Cap	Rs 674.09 crore

Anuh Pharma Ltd. (ANUHPHR) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Anuh Pharma Ltd. (ANUHPHR) has a P/E ratio of 18.43x, which is below the benchmark median of 32.83x, a difference of -43.86%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Anuh Pharma Ltd. (ANUHPHR) has a ROE of 12.1%, which is above the benchmark median of 11.78%, a difference of +2.72%. Anuh Pharma Ltd. (ANUHPHR) has a ROCE of 16.02%, which is above the benchmark median of 13.65%, a difference of +17.36%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,55,633.71	37.67	5.27	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,41,576.41	82.59	13.68	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,84,478.41	84.58	20.55	26.76	19.27
Cipla Ltd.	CIPLA	1,11,888.39	33.19	3.18	11.83	16
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,11,820.18	24.78	4.15	19.69	21.39

Anuh Pharma Ltd. (ANUHPHR) has a P/E ratio of 18.43x compared with the displayed peer median of 37.67x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.1% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 16.02% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Anuh Pharma Ltd. (ANUHPHR) has a market capitalisation of Rs 814.22 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Anuh Pharma

• The Anuh Pharma Share Price rose 11.12% to Rs 90.27, placing the stock among the day’s stronger movers.
• The price moved from Rs 80.84 to Rs 90.27, with the latest print matching the day’s high.
• Market cap of Rs 814.22 Cr keeps Anuh Pharma in the mid-small-cap bracket within Healthcare.
• P/E of 18.43 and P/B of 2.24 compare below the industry median, which supports valuation tracking.
• ROE of 12.1 and ROCE of 16.02 give the Anuh Pharma Fundamental Analysis story some balance.

About Anuh Pharma

Anuh Pharma Ltd. operates in the Pharmaceuticals & Drugs industry within Healthcare. The company’s stock is listed under ANUHPHR and is tracked by investors who follow Anuh Pharma NSE and Anuh Pharma BSE updates for price movements, valuation and market cap context. Based on the latest Univest figures, the company’s financial profile includes EPS of Rs 4.41, book value of Rs 36.28 and dividend yield of 1.85%, which help frame the Anuh Pharma Share Price in a broader company overview.

For market participants, the company’s relevance comes from how it combines a modest market capitalisation with measurable returns on equity and capital employed. That makes Anuh Pharma Stock Analysis useful for readers who want to compare a smaller pharma name with much larger listed peers. The business sits in a sector where fundamental analysis and peer comparison often matter more than broad market enthusiasm, so Anuh Pharma Share News is usually read through the lens of price, valuation and company-specific financial metrics.

Frequently Asked Questions

Why did Anuh Pharma Share Price rise today?

Ans. The latest Univest data confirms an 11.12% rise to Rs 90.27, but it does not establish a company-specific catalyst. Investors are therefore reading the move mainly through price action, valuation and sector context.

What is Anuh Pharma Share Price today?

Ans. Anuh Pharma Share Price was Rs 90.27 at the latest check. It was up Rs 9.03, or 11.12%, from the previous close of Rs 81.24 during the ongoing session.

What is the market cap of Anuh Pharma?

Ans. Anuh Pharma’s market capitalisation stands at Rs 814.22 Cr. That places it above the same-industry median of Rs 674.09 Cr across a benchmark set of 204 companies. The company operates in the Healthcare sector.

Is Anuh Pharma expensive compared with pharma peers?

Ans. On valuation, Anuh Pharma looks modest versus many peers. Its P/E of 18.43 is below the industry median of 32.83 and below several large pharma names in the comparison set.

How does Anuh Pharma compare on profitability ratios?

Ans. Anuh Pharma reports ROE of 12.1 and ROCE of 16.02. Both sit above the same-industry median, which gives the stock a reasonable profitability backdrop for Anuh Pharma Fundamental Analysis.

What are Anuh Pharma EPS and book value?

Ans. Anuh Pharma’s EPS is Rs 4.41 and book value is Rs 36.28. EPS shows earnings attributable to each share, while book value reflects the accounting net worth behind each share.

What is Anuh Pharma dividend yield?

Ans. Anuh Pharma has a dividend yield of 1.85%. This is a historical or current payout measure, so it helps describe income context but does not guarantee future distributions.

Which sector and industry does Anuh Pharma belong to?

Ans. Anuh Pharma belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That places the Anuh Pharma Share Price within a benchmarked peer group of 204 companies in the same industry.

Track Anuh Pharma Share Price on Univest

Use Anuh Pharma Ltd. (ANUHPHR) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Investors can track Anuh Pharma Share Price on Univest for live price updates, market cap, valuation ratios, financial analysis, sector context and peer comparison. Univest also helps readers follow Anuh Pharma Stock News, Anuh Pharma Latest News and Anuh Pharma Share Price Today in one place, making it easier to monitor the stock as market updates evolve.